2015-2016 Session
Change SessionSenate Committee on Finance (Room 6)
The Senate Committee on Finance has jurisdiction over matters affecting the revenues of the State or its instrumentalities and relating to banks; trust companies; insurance; utility companies; and private and quasi-public corporations, including other companies subject to regulation by the Public Service Board.
- Meeting Schedule
-
- No meeting is currently scheduled
- Previous Meetings
Documents & Handouts
Browse documents below or use document search.
Materials posted on this page are for informational purposes only and may not include all material received by the Committee. The Committee is not responsible for the accuracy of posted material, and posting does not represent approval or endorsement by the Committee or the Vermont General Assembly.
- Back
- Documents/2016/WorkGroups/Senate Finance/Bills/S.216
- Friday, March 11, 2016
- S.216 Draft No. 2.5 Dated 3.11.16 Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Wednesday, March 9, 2016
- 2017 QHP Certification Timeline Revised 3.3.16 Devon Green, Special Counsel, Agency of Administration
- S.216 Proposed Amendment RX MOOP Devon Green, Special Counsel, Agency of Administration
- MOOP letter Gail Zatz, Zatz and Renfrew Consulting, on behalf of concerned organizations
- Tuesday, February 23, 2016
- S.216: Vermont Single Formulary -S.216 Written Testimony Cory Gustafson
- S.216: S.216 CVS Health Written Testimony Jamie Feehan
- S.216: Draft No. 1.2 Dated 2.17.2016 Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- S.216: Presentation on S. 216 - An act relating to prescription drug formularies Susan Barrett
- Wednesday, February 17, 2016
- S.216 Price A Drug Website Snapshots Brian Murphy, Pharmacy Program Director, Blue Cross Blue Shield
- S.216 45 CFR Section 156.22(d)(1) Charles Storrow, Lobbyist, Express Scripts, Inc.
- S.216 Draft No 1.2 Dated 2.17.16 Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Tuesday, February 16, 2016
- S.216 Formulary Transparency Bill Jill Sudhoff-Guerin, Vermont Government Relations Director, American Cancer Society Cancer Action Network, Inc.
- S.216 Testimony Jill Sudhoff-Guerin, Vermont Government Relations Director, American Cancer Society Cancer Action Network, Inc.
Bills In Senate Committee on Finance
Bills that are currently in committee.
2015 - 2016 Legislative Session
| Bill | Title | Sponsor |
|---|
Bills Out of Senate Committee on Finance
Bills sponsored by the committee, and bills reported out of committee. Includes bills where the committee has been relieved of responsibility.
2015 - 2016 Legislative Session
| Bill | Title | Sponsor | Act # | Year |
|---|
Bills Referred to Senate Committee on Finance
Bills that were in committee at any time. Does not include bills sponsored by Committee.
2015 - 2016 Legislative Session
| Bill | Title | Sponsor | Act # | Year |
|---|
Bills Sponsored by Senate Committee on Finance
2015 - 2016 Legislative Session
| Bill | Title | Act # |
|---|
Legislative language and other materials posted on this page are subject to frequent change and may not reflect the Committee's most recent discussions or actions. Please check back often for updated materials.
